In PD, a dual mechanism that includes inhibition of MAO-B, as well as adenosineA2A receptor blockade, offers a novel therapeutic approach to preventneuronal cell death (Figure 9,Figure 10). This evidence concerns the gene MAOB and Parkinson disease.